世界の標的DNA RNAシーケンシングの市場規模は2023年に101億2000万ドルと評価され、2024年から2030年にかけて19.4%のCAGRで成長すると予測されます。DNAおよびRNAシーケンシングは、遺伝情報と生物学的機能を理解するために重要なDNAまたはRNA分子中のヌクレオチドの正確な配列を可能にします。これは、標的のDNA/RNA構造が特定の遺伝子または領域に焦点を当てているため、診断と個別化治療の精度が向上します。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Targeted DNA RNA Sequencing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
4.3. NGS
4.3.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Method Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1. Exome Sequencing
4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Enrichment Sequencing
4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Amplicon Sequencing
4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Others
4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1. Cancer Gene Sequencing
4.3.3.2. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.3. Inherited Disease Screening
4.3.3.4. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.5. Drug Development
4.3.3.6. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.7. Forensic Genomics
4.3.3.8. Forensic Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.9. 16S Ribosomal RNA (rRNA)
4.3.3.10. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Others
4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, 2023 & 2030 (USD Million)
5.3. Pre-sequencing
5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Sequencing
5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Data Analysis
5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Human Biomedical Research
6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Plant & Animal Sciences
6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Drug Discovery
6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, 2023 & 2030 (USD Million)
7.3. DNA Based Targeted Sequencing
7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. RNA Based Targeted Sequencing
7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
8.3. Academic Research
8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Hospitals & Clinics
8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Pharma & Biotech Entities
8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis
9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2023 & 2030 (USD Million)
9.2. North America
9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. UK Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Denmark Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Sweden Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Norway Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. China
9.4.2.1. China Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Japan Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. India Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. South Korea
9.4.5.1. South Korea Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. Australia
9.4.6.1. Australia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Saudi Arabia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. UAE
9.6.3.1. UAE Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. South Africa
9.6.4.1. South Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Illumina
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/Strategic Initiatives
10.4.2. F. Hoffman-La Roche Ltd.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/Strategic Initiatives
10.4.3. QIAGEN
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/Strategic Initiatives
10.4.4. Thermo Fisher Scientific, Inc.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/Strategic Initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Oxford Nanopore Technologies
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/Strategic Initiatives
10.4.7. PierianDx
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/Strategic Initiatives
10.4.8. Genomatix GmbH
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/Strategic Initiatives
10.4.9. DNASTAR, Inc.
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/Strategic Initiatives
10.4.10. Perkin Elmer, Inc.
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/Strategic Initiatives
